Categories: Stock Market News

Biogen proposes to purchase remaining stake in Sage in $442 million deal


(Reuters) – Drugmaker Biogen (NASDAQ:BIIB) will purchase all excellent shares of Sage Therapeutics that it doesn’t already personal for $7.22 apiece, a submitting confirmed on Friday, sending the latter’s replenish 34% in prolonged commerce.

As per the submitting, Biogen has a ten.2% stake in Sage Therapeutics. The provide worth, representing a 30% premium to the inventory’s shut on Friday, values Sage’s fairness at $441.7 million, in accordance with Reuters calculations.

Biogen has been navigating a gradual pick-up in gross sales for its Alzheimer’s drug Leqembi in the US after issues over price, efficacy and negative effects.

Sage, whose shares fell 74.9% final yr, deserted the event of its drug dalzanemdor after a number of trial failures. The corporate stated in November that it’ll give attention to its postpartum melancholy drug, Zurzuvae, which it developed in partnership with Biogen.

In July, Sage additionally scrapped the event of one other neurological dysfunction drug it was growing with Biogen.

admin

Share
Published by
admin

Recent Posts

US Economic system Was Already Sputtering Earlier than Commerce Ache Kicked In

(Bloomberg) -- Subscribe to Economics Each day for the newest information and evaluation. After cruising…

58 minutes ago

People count on the financial system to bitter — here is when the information may present it

People are feeling more and more downbeat in regards to the financial outlook. Some Wall…

7 hours ago

How Powell may gain advantage Trump as a ‘scapegoat’ if financial system slumps

President Trump backed away from his threats to take away Federal Reserve Chair Jerome Powell.…

7 hours ago

Home GOP Drafts Cuts to Federal Worker Pension System

(Bloomberg) -- Federal worker pension advantages are set to be pared again in Republicans’ big…

8 hours ago

What To Anticipate From Wednesday’s Report On Financial Development

Eric Thayer/Bloomberg by way of Getty Photos The U.S. GDP is anticipated to have grown…

9 hours ago

World breathes sigh of reduction as Trump spares Fed, IMF

By Francesco Canepa, Jan Strupczewski and Leika Kihara WASHINGTON (Reuters) -International policymakers gathering in Washington…

12 hours ago